91���ϳ���Ƭ

About 91���ϳ���Ƭ Therapeutics

‍

91���ϳ���Ƭ Therapeutics is a clinical-stage biotech company advancing novel antigen modulation technology to guide the immune system. Our approach modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system. We are progressing first-in-class antigen modulators to treat people living with 91���ϳ���Ƭ, autoimmune disorders, and infectious diseases.

‍

91���ϳ���Ƭ is headquartered in Oxford, UK.

‍

More information: Website |

‍

Media enquiries

Patrick White, Head of Communications

+44 (0)1235 644 970

patrick.white@gwt.bio

‍